{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:30:52Z","timestamp":1707525052265},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,21]]},"DOI":"10.7759\/cureus.36455","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T10:49:42Z","timestamp":1679395782000},"source":"Crossref","is-referenced-by-count":0,"title":["Mild Pancreatitis Induced by Linagliptin Revealed by a Medication Review"],"prefix":"10.7759","author":[{"given":"Harish","family":"Gidda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inderpal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bola","family":"Nashed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSOTT.S7004","article-title":"Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes - a review","volume":"3","author":"Hansen KB","year":"2010","unstructured":"Hansen KB, Vilsb\u00f8ll T, Knop FK. Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes - a review. Diabetes Metab Syndr Obes. 2010, 3:155-63. 10.2147\/DMSOTT.S7004","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dci16-0035","article-title":"DPP-4 inhibitor-related pancreatitis: rare but real!","volume":"40","author":"DeVries JH","year":"2017","unstructured":"DeVries JH, Rosenstock J. DPP-4 inhibitor-related pancreatitis: rare but real!. Diabetes Care. 2017, 40:161-3. 10.2337\/dci16-0035","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4158\/ACCR-2019-0307","article-title":"Linagliptin-induced pancreatitis","volume":"6","author":"Mosquera JE","year":"2020","unstructured":"Mosquera JE, Torres N, Restrepo J, Ruz-Pau C, Suryanarayanan S. Linagliptin-induced pancreatitis. AACE Clin Case Rep. 2020, 6:e37-9. 10.4158\/ACCR-2019-0307","journal-title":"AACE Clin Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013284","article-title":"Linagliptin-related pancreatitis in a diabetic patient with biliary calculus: a case report","volume":"97","author":"Sevencan NO","year":"2018","unstructured":"Sevencan NO, Ozkan AE, Kayhan B. Linagliptin-related pancreatitis in a diabetic patient with biliary calculus: a case report. Medicine (Baltimore). 2018, 97:e13284. 10.1097\/MD.0000000000013284","journal-title":"Medicine (Baltimore)"},{"key":"ref5","unstructured":"Dipeptidylpeptidase-4 inhibitors. risk of acute pancreatitis. (2012). Accessed: February 20, 2023: https:\/\/www.gov.uk\/drug-safety-update\/dipeptidylpeptidase-4-inhibitors-risk-of-acute-pancreatitis."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00856.x","article-title":"Practice guidelines in acute pancreatitis","volume":"101","author":"Banks PA","year":"2006","unstructured":"Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006, 101:2379-400. 10.1111\/j.1572-0241.2006.00856.x","journal-title":"Am J Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19488","article-title":"Another case of lisinopril-induced acute pancreatitis","volume":"13","author":"Baum J","year":"2021","unstructured":"Baum J, Walfish A, Fenster M, Miller Y, Kresch M. Another case of lisinopril-induced acute pancreatitis. Cureus. 2021, 13:e19488. 10.7759\/cureus.19488","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629120-00004","article-title":"Statins and pancreatitis: a systematic review of observational studies and spontaneous case reports","volume":"29","author":"Singh S","year":"2006","unstructured":"Singh S, Loke YK. Statins and pancreatitis: a systematic review of observational studies and spontaneous case reports. Drug Saf. 2006, 29:1123-32. 10.2165\/00002018-200629120-00004","journal-title":"Drug Saf"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1707","article-title":"Combined analysis of three large interventional trials with gliptins indicates increased incidence of acute pancreatitis in patients with type 2 diabetes","volume":"40","author":"Tk\u00e1\u010d I","year":"2017","unstructured":"Tk\u00e1\u010d I, Raz I. Combined analysis of three large interventional trials with gliptins indicates increased incidence of acute pancreatitis in patients with type 2 diabetes. Diabetes Care. 2017, 40:284-6. 10.2337\/dc15-1707","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.18269","article-title":"Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial","volume":"321","author":"Rosenstock J","year":"2019","unstructured":"Rosenstock J, Perkovic V, Johansen OE, et al.. Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial. JAMA. 2019, 321:69-79. 10.1001\/jama.2018.18269","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1109","article-title":"Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the KrasG12D mouse model","volume":"61","author":"Gier B","year":"2012","unstructured":"Gier B, Matveyenko AV, Kirakossian D, Dawson D, Dry SM, Butler PC. Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the KrasG12D mouse model. Diabetes. 2012, 61:1250-62. 10.2337\/db11-1109","journal-title":"Diabetes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231883","article-title":"Drug induced pancreatitis: a systematic review of case reports to determine potential drug associations","volume":"15","author":"Wolfe D","year":"2020","unstructured":"Wolfe D, Kanji S, Yazdi F, et al.. Drug induced pancreatitis: a systematic review of case reports to determine potential drug associations. PLoS One. 2020, 15:e0231883. 10.1371\/journal.pone.0231883","journal-title":"PLoS One"},{"key":"ref13","article-title":"Drug-induced acute pancreatitis: a review","volume":"15","author":"Jones MR","year":"2015","unstructured":"Jones MR, Hall OM, Kaye AM, Kaye AD. Drug-induced acute pancreatitis: a review. Ochsner J. 2015, 15:45-51.","journal-title":"Ochsner J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/142879-mild-pancreatitis-induced-by-linagliptin-revealed-by-a-medication-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:56:19Z","timestamp":1707508579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/142879-mild-pancreatitis-induced-by-linagliptin-revealed-by-a-medication-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.36455","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,21]]}}}